Surims Ltd Logo
 
 
 
 
 
 
Nexus Pharmaceuticals Logo  
 
 
Basic Profile
 
If you'd like to claim this company profile for Nexus Pharmaceuticals, please Contact Us.
 

Nexus Pharmaceuticals News

The latest news, announcements and press releases from Nexus Pharmaceuticals.

 
 
16
April
2021
16th April 2021
 

Nexus Pharmaceuticals sets month for $100M plant opening, preps drug for treating Covid patients

PLEASANT PRAIRIE, WI.–Nexus Pharmaceuticals Inc. plans to complete its nearly $100 million Pleasant Prairie sterile injectables plant in April 2021 and a company executive said it will help address the United States’ reliance on foreign pharmaceutical suppliers magnified by the Covid-19 pandemic.






Privately held Nexus Pharmaceuticals, of Lincolnshire, Illinois, announced in July 2019 that the first phase of its multi-year project would open in 2021 but didn’t specify an opening timeframe. Production should be underway in the facility by early 2022 with 77 employees working there, said chief financial officer Usman Ahmed.


“It’s going good — so far so good,” Ahmed said of the project.


The three-story, 84,000-square-foot facility is being built in the Prairie Highlands Corporate Park, which is west of Interstate 94 across from LakeView Corporate Park and next to a new Aurora Health Care complex. The total project cost is just under $100 million including construction, real estate and equipment, Ahmed said.





 
Read the full story »
 
 
 

Claim This Profile

This is the News section of the company profile page for Nexus Pharmaceuticals on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

 
 
Nexus Pharmaceuticals company details, activities, contacts and reviews.
 
Nexus Pharmaceuticals partnership and licensing opportunities.
 
Nexus Pharmaceuticals latest news, announcements and press releases.
 
Nexus Pharmaceuticals documents, images and videos.
 
Nexus Pharmaceuticals global factories, offices and locations.
 
Nexus Pharmaceuticals legal and financial information.
 
 
 
 
 
 
 

About Us

Surims Ltd is a consultancy established in 2003 supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own on-boarding and supplier management activities. Further information on our software services can be found at https://www.surims.com.

 
 
 

Get in Touch

The Pharmaceutical Services Directory
info@pharmaservicesdirectory.com

 
 

© 2021 Surims Ltd | All Rights Reserved.